Abstract
Objective
In 2011, a multidisciplinary hypertrophic cardiomyopathy (HCM) program with a dedicated myectomy surgeon was implemented at our institution. We hypothesized that a dedicated approach allows better identification and management of mitral regurgitation (MR) during septal myectomy (SM) for obstructive HCM with significant mitral regurgitation.
Methods
Between 2006 and 2018, 181 patients had SM at our institution. This study consists of 53 patients with preoperative moderate or greater MR associated with systolic anterior motion who underwent isolated SM with or without mitral intervention. Patients were divided into those who underwent SM by a dedicated myectomy surgeon (group D, n = 31) or by a non-dedicated surgeon (group ND, n = 22). Primary outcome of interest was rate of mitral valve replacement (MVR) at SM. Secondary outcomes include in-hospital mortality, need for permanent pacemaker, mitral valve reoperation, and residual MR and left ventricular outflow tract gradient on postoperative echocardiography.
Results
12 patients (55%) had a concomitant MVR during septal myectomy in group ND compared to 2 patients (6%) in group D (p < 0.01). Among patients who did not undergo MVR, patients in group D less commonly had residual MR than patients in ND after SM (p < 0.01). Group D had 100% survival with NYHA class I in 94% patients at follow-up visit (p = 0.01). Reoperation for MVR was required in four patients in group ND vs. none in group D (p < 0.01).
Conclusions
A dedicated surgeon is able to spare the mitral valve in patients undergoing SM. This study emphasizes the importance of surgical expertise in this cohort.
Similar content being viewed by others
Abbreviations
- SM:
-
Septal myectomy
- HCM:
-
Hypertrophic cardiomyopathy
- LVOT:
-
Left ventricular outflow tract
- MV:
-
Mitral valve
- MVR:
-
Mitral valve replacement
- SAM:
-
Systolic anterior motion
- TEE:
-
Transesophageal echocardiogram
- TTE:
-
Transthoracic echocardiogram
References
Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015. https://doi.org/10.1016/j.jacc.2015.01.019.
Maron BJ. Hypertrophic Cardiomyopathy. Lancet. 1997. https://doi.org/10.1148/radiol.10090526.
Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary. J Thorac Cardiovasc Surg. 2011;142(6):1303–38. https://doi.org/10.1016/j.jtcvs.2011.10.019.
Maron BJ, Dearani JA, Ommen SR, et al. Low operative mortality achieved with surgical septal myectomy role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction. J Am Coll Cardiol. 2015. https://doi.org/10.1016/j.jacc.2015.06.1333.
Minakata K, Dearani JA, Schaff HV, O’Leary PW, Ommen SR, Danielson GK. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 2005;80(3):851–6. https://doi.org/10.1016/j.athoracsur.2005.03.108.
Maron BJ, Dearani JA, Maron MS, et al. Why we need more septal myectomy surgeons: an emerging recognition. J Thorac Cardiovasc Surg. 2017;154(5):1681–5. https://doi.org/10.1016/j.jtcvs.2016.12.038.
Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013. https://doi.org/10.1016/S0140-6736(12)60397-3.
Takayama H, Chung WK, Maurer MS, Ginns JN. Hypertrophic cardiomyopathy: new approaches and a time to reappraise older approaches. J Thorac Cardiovasc Surg. 2016;152(4):983–8. https://doi.org/10.1016/J.JTCVS.2016.06.034.
Morrow AG, Fogarty TJ, Hannah H, Braunwald E. Operative treatment in idiopathic hypertrophic subaortic stenosis. Circulation. 1968;37:589–96.
Schaff HV, Said SM. Transaortic extended septal myectomy for hypertrophic cardiomyopathy. Oper Tech Thorac Cardiovasc Surg. 2012;17(4):238–50. https://doi.org/10.1053/j.optechstcvs.2012.04.002.
Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The mitral valve in obstructive hypertrophic cardiomyopathy a test in context. J Am Coll Cardiol. 2016;67(15):1846–58. https://doi.org/10.1016/j.jacc.2016.01.071.
Dearani JA, Ommen SR, Gersh BJ, Schaff HV, Danielson GK. Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med. 2007. https://doi.org/10.1038/ncpcardio0965.
Collis R, Watkinson O, O’Mahony C, et al. Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Eur J Heart Fail. 2017. https://doi.org/10.1002/ejhf.1038.
Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg. 2004;127(2):481–9. https://doi.org/10.1016/j.jtcvs.2003.09.040.
Kato TS, Takayama H, Yoshizawa S, et al. Cardiac transplantation in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2012. https://doi.org/10.1016/j.amjcard.2012.04.030.
Takayama H, Yu SN, Sorabella R, et al. Virtual septal myectomy for preoperative planning in hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2018. https://doi.org/10.1016/J.JTCVS.2018.10.138.
Fukuhara S, Edwards S, Kurlansky P, Takayama H. Bimanual examination for septal myectomy for hypertrophic cardiomyopathy. Interact Cardiovasc Thorac Surg. 2014;19(5):735–7. https://doi.org/10.1093/icvts/ivu251.
Panaich SS, Badheka AO, Chothani A, et al. Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998–2010]). Am J Cardiol. 2014. https://doi.org/10.1016/j.amjcard.2014.07.075.
Kim LK, Swaminathan RV, Looser P, et al. Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy. JAMA Cardiol. 2016. https://doi.org/10.1001/jamacardio.2016.0252.
Said SM, Schaff HV. Surgical treatment of hypertrophic cardiomyopathy. Semin Thorac Cardiovasc Surg. 2013. https://doi.org/10.1053/j.semtcvs.2014.01.001.
Hong JH, Schaff HV, Nishimura RA, et al. Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures. J Am Coll Cardiol. 2016. https://doi.org/10.1016/j.jacc.2016.07.735.
Takayama H, Nguyen S, Weiner SD. Commentary: watch how the mitral valve is repaired at septal myectomy (and root replacement). J Thorac Cardiovasc Surg. 2020. https://doi.org/10.1016/j.jtcvs.2019.09.128.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Yuichi Shimada has received research funding from the American Heart Association. The remaining authors have no financial disclosures.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yu, S.N., Nakanishi, K., Ginns, J.N. et al. Importance of surgical expertise in septal myectomy for obstructive hypertrophic cardiomyopathy. Gen Thorac Cardiovasc Surg 68, 1094–1100 (2020). https://doi.org/10.1007/s11748-020-01320-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-020-01320-7